Cargando…
Humanized anti-TLR4 monoclonal antibody ameliorates lipopolysaccharide-related acute kidney injury by inhibiting TLR4/NF-κB signaling
A humanized anti-Toll-like receptor 4 (TLR4) monoclonal antibody (mAb) was previously produced using phage antibody library technology, and it was found that the mAb could effectively ameliorate lipopolysaccharide (LPS)-induced damage in macrophages. The present study investigated the protective eff...
Autores principales: | Zhang, Qiuhua, Wang, Liang, Wu, Mian, Liu, Xiaobin, Zhu, Yushan, Zhu, Jin, Xing, Changying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240183/ https://www.ncbi.nlm.nih.gov/pubmed/34184086 http://dx.doi.org/10.3892/mmr.2021.12245 |
Ejemplares similares
-
Berberine ameliorates diabetic nephropathy by inhibiting TLR4/NF-κB pathway
por: Zhu, Liping, et al.
Publicado: (2018) -
The Fab Fragment of a Humanized Anti-Toll Like Receptor 4 (TLR4) Monoclonal Antibody Reduces the Lipopolysaccharide Response via TLR4 in Mouse Macrophages
por: Cai, Binggang, et al.
Publicado: (2015) -
Human monoclonal anti-TLR4 antibody negatively regulates lipopolysaccharide-induced inflammatory responses in mouse macrophages
por: Wang, Yiwen, et al.
Publicado: (2020) -
Epigallocatechin-3-gallate ameliorates lipopolysaccharide-induced acute lung injury by suppression of TLR4/NF-κB signaling activation
por: Wang, Jia, et al.
Publicado: (2019) -
Lipopolysaccharide Downregulates CD163 Expression to Inhibit PRRSV Infection via TLR4-NF-κB Pathway
por: Zhu, Zhenbang, et al.
Publicado: (2020)